3 hours Jasper Therapeutics, Inc. (NASDAQ:JSPR) Receives Average Recommendation of “Buy” from AnalystsMarketBeat
Jasper Therapeutics, Inc. (NASDAQ:JSPR – Get Free Report) has been given a consensus recommendation of “Buy” by the ten ratings firms that are presently covering the company, MarketBeat.com reports. Ten research analysts have rated the stock with a bu…
X